These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 850149)

  • 1. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium suppresses elevated behavioural activity and brain catecholamines in developing hyperthyroid rats.
    Rastogi RB; Singhal RL
    Can J Physiol Pharmacol; 1977 Jun; 55(3):490-5. PubMed ID: 18270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional neurochemical studies on the effect of beta, beta'-iminodipropionitrile (IDPN) in the rat.
    Langlais PJ; Huang PC; Gabay S
    J Neurosci Res; 1975; 1(5-6):419-35. PubMed ID: 1241588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain.
    Stancheva S; Grahovska T; Petkov VV
    Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E; Grondin L; Reader TA
    J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes-induced alteration in brain monoamine metabolism in rats.
    Bitar M; Koulu M; Rapoport SI; Linnoila M
    J Pharmacol Exp Ther; 1986 Feb; 236(2):432-7. PubMed ID: 2418197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat.
    Hedner T; Lundborg P
    Med Biol; 1981 Aug; 59(4):212-23. PubMed ID: 6803074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of euphylline and halidor on several indices of catecholamine and serotonin metabolism in the brains and blood of rats].
    Saratikov AS; Fisanova LL; Marina TF
    Vopr Med Khim; 1977; 23(2):237-41. PubMed ID: 883160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychopharmacological study of enkephalins, with special reference to the relation between behavioral profiles and brain monoamines].
    Kameyama T; Ukai M; Noma S
    Yakubutsu Seishin Kodo; 1981 Oct; 1(1):21-8. PubMed ID: 6198817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural and neurochemical consequences of neonatal exposure to lead in rats.
    Dubas TC; Hrdina PD
    J Environ Pathol Toxicol; 1978; 2(2):471-84. PubMed ID: 739226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prolonged vasopressin administration on the level and metabolism of catecholamines in the rat brain and kidneys.
    Szmigielska H
    Acta Physiol Pol; 1976; 27(3):259-64. PubMed ID: 7918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.